Robbins Arroyo LLP Is Investigating the Officers and Directors of Aegerion Pharmaceuticals, Inc. (AEGR) on Behalf of Shareholders

SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Aegerion Pharmaceuticals, Inc. (NASDAQGS: AEGR) violated their legal obligations to the company and its shareholders in connection with alleged violations of drug marketing requirements, securities laws, and the Health Insurance Portability and Accountability Act ("HIPAA"). Aegerion, a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States.